Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at THB 3.2T, ahead of Eli Lilly (THB 2.21T) and Merck & Co (THB 2.21T). Figures as of 20 Nov 2026, 22:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonTHB 3.2T
- Median
- THB 46.9B
- Combined market value
- THB 126.86T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | THB 3.2T | THB 22.11T | THB 9,185.16 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | THB 2.21T | THB 40.75T | THB 45,747.86 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | THB 2.21T | THB 11.2T | THB 4,541.13 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | THB 2.13T | THB 5.3T | THB 930.50 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | THB 2.08T | THB 17.18T | THB 9,719.35 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | THB 1.64T | THB 4.08T | THB 1,996.85 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | THB 1.51T | THB 6.06T | THB 3,497.88 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | THB 487.1B | THB 3.23T | THB 31,266.63 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | THB 485.6B | THB 764.3B | THB 666.63 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | THB 407.6B | THB 4.43T | THB 17,490.08 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | THB 321.5B | THB 1.09T | THB 2,686.58 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | THB 160.1B | THB 436.9B | THB 874.13 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | THB 126.1B | THB 654.2B | THB 4,884.13 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | THB 109.4B | THB 397.4B | THB 2,051.52 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | THB 108.1B | THB 802.3B | THB 18,838.63 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | THB 102.5B | THB 249.9B | THB 717.24 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | THB 80.8B | THB 1.34T | THB 2,324.56 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | THB 58.8B | THB 160.1B | THB 1,916.02 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | THB 34.9B | THB 100.5B | THB 517.89 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | THB 32.5B | THB 299.1B | THB 12,874.24 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | THB 32B | THB 150.3B | THB 902.66 | 2.35% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | THB 28.2B | THB 198.6B | THB 1,404.93 | 5.22% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | THB 25.9B | THB 236.5B | THB 2,160.54 | 2.09% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | THB 21.7B | THB 231.1B | THB 4,393.07 | 4.66% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | THB 20.9B | THB 325.1B | THB 2,151.03 | 2.37% down | 103% up | ||
| 26 | InsmedINSM · Health Care | THB 20.6B | THB 1.05T | THB 4,799.57 | 2.17% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | THB 17.7B | THB 213.1B | THB 3,264.57 | 0.65% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | THB 17.1B | THB 503B | THB 2,581.98 | 2.75% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | THB 16.7B | THB 153.2B | THB 1,596.12 | 2.69% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | THB 9.1B | THB 194.9B | THB 9,741.43 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | THB 6.4B | THB 264.5B | THB 3,815.75 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | THB 3B | THB 240.2B | THB 1,724.49 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | THB 1.6B | THB 269.1B | THB 4,122.74 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | THB 69.1M | THB 161.7B | THB 2,871.32 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | THB 0 | THB 301.5B | THB 3,174.24 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | THB 0 | THB 285.2B | THB 10,202.60 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9600 THB). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (THB 3.2T), Eli Lilly (THB 2.21T) and Merck & Co (THB 2.21T) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 22:06 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of THB 126.86T as of 20 Nov 2026, 22:06 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.